AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,112,000 | +81.4% | 404,020 | -10.1% | 0.00% | +100.0% |
| Q2 2022 | $3,370,000 | +5.1% | 449,312 | +16.9% | 0.00% | 0.0% |
| Q1 2022 | $3,205,000 | +20.1% | 384,338 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $2,669,000 | -37.4% | 380,269 | +1.7% | 0.00% | 0.0% |
| Q3 2021 | $4,262,000 | -37.9% | 373,859 | -12.8% | 0.00% | -50.0% |
| Q2 2021 | $6,862,000 | +6.1% | 428,637 | +18.4% | 0.00% | 0.0% |
| Q1 2021 | $6,468,000 | +17.7% | 361,945 | -11.0% | 0.00% | 0.0% |
| Q4 2020 | $5,495,000 | -22.0% | 406,733 | -32.0% | 0.00% | -33.3% |
| Q3 2020 | $7,045,000 | -18.6% | 598,484 | +2.0% | 0.00% | -25.0% |
| Q2 2020 | $8,659,000 | +26.1% | 586,690 | +15.4% | 0.00% | +33.3% |
| Q1 2020 | $6,866,000 | +9.7% | 508,567 | +96.5% | 0.00% | +50.0% |
| Q4 2019 | $6,257,000 | +55.0% | 258,864 | +23.3% | 0.00% | 0.0% |
| Q3 2019 | $4,036,000 | -30.7% | 209,978 | +6.5% | 0.00% | 0.0% |
| Q2 2019 | $5,824,000 | +1000.9% | 197,090 | +1590.2% | 0.00% | -33.3% |
| Q1 2017 | $529,000 | -12.6% | 11,661 | -27.0% | 0.00% | 0.0% |
| Q4 2016 | $605,000 | +3.4% | 15,982 | +3.1% | 0.00% | 0.0% |
| Q3 2016 | $585,000 | – | 15,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|